Table 4.
Two-way analysis of treatment × time interaction in psychometric tests of active and placebo groups for female subjects.
| Test | Start-Up | Follow-Up | Treatment × Time Interaction | ||||
|---|---|---|---|---|---|---|---|
| Active a | Placebo a | Active a | Placebo a | Active a | Placebo a | p-Value b | |
| MoCA | 24.9 ± 2.2 | 26.8 ± 2.3 | 26.8 ± 2.4 | 26.9 ± 1.9 | 1.9 ±2.1 | 0.2 ± 2.0 | 0.0103 * |
| MMSE | 26.9 ± 2.1 | 27.7 ± 1.4 | 28.1 ± 1.4 | 28.3 ± 1.2 | 1.1 ±2.3 | 0.6 ± 2.0 | 0.5167 |
| WMS-DR | 7.0 ± 2.8 | 5.6 ± 3.7 | 10.0 ± 3.7 | 7.6 ± 3.6 | 3.0 ± 2.7 | 2.0 ± 2.3 | 0.2204 |
| BIS-11 | 61.6 ± 5.9 | 64.3 ± 6.0 | 60.2 ± 10.0 | 64.1 ± 5.3 | −1.4 ± 5.1 | −0.2 ± 4.7 | 0.5112 |
a Mean ± Standard Deviation; b Changes between start-up and follow-up. * p < 0.05.